Published in Nephrol Dial Transplant on July 01, 1996
Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2009) 2.42
Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol (2012) 1.06
Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Braz J Med Biol Res (2014) 0.80
Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess. Clin Exp Nephrol (2010) 0.75
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model. Kidney Int (2007) 1.66
Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect. Int J Clin Pharmacol Ther Toxicol (1982) 1.65
Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b. Nephrol Dial Transplant (1995) 1.59
Safe preservation of human renal cadaver transplants by Euro-Collins solution up to 50 hours. Transplant Proc (1981) 1.50
Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int (1999) 1.46
Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int (2001) 1.43
Bone mass evolution after renal transplantation. Kidney Int (2001) 1.38
No association between Alport's syndrome and antithyroid antibodies. Nephrol Dial Transplant (1992) 1.38
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int (1994) 1.38
Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc (1987) 1.35
Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int (1998) 1.32
Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res (1996) 1.28
Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet (2000) 1.24
Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet (1986) 1.20
Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet (2002) 1.20
Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int (1997) 1.18
Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int (1999) 1.17
Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int (1995) 1.16
Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium. Lancet (1984) 1.15
Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis. Clin Nephrol (1997) 1.07
Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. Am J Kidney Dis (1986) 1.06
Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int (1993) 1.05
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis (1997) 1.05
Genetics of hypercalciuric stone forming diseases. Kidney Int (2007) 1.04
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation (1994) 1.03
Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. J Am Soc Nephrol (1998) 1.02
Outcome of patients with tuberous sclerosis after renal transplantation. Transplantation (1990) 1.02
Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol (1996) 1.02
Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med (1977) 1.01
Low molecular weight proteinuria in human immunodeficiency virus-infected patients. Am J Kidney Dis (1996) 1.00
Bee stings and acute tubular necrosis. Nephron (1982) 0.99
Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int (1997) 0.98
Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int (2001) 0.98
Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid Communication. Kidney Int (2001) 0.98
Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int (1998) 0.97
Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int (1994) 0.97
Multiple spontaneous ruptures of tendons in renal transplant recipient. Br Med J (Clin Res Ed) (1984) 0.96
Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl (2000) 0.96
Captopril-induced acute reversible renal failure. Nephron (1983) 0.96
Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int (1995) 0.95
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? J Am Soc Nephrol (2001) 0.95
Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int (1994) 0.94
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Hemolytic uremic syndrome in three adult siblings: a familial study and evolution. Clin Nephrol (1987) 0.94
Course of Henoch-Schönlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation (1994) 0.94
Hypertension after renal transplantation. Br Med J (1976) 0.94
Increase of physical activity level after successful renal transplantation: a 5 year follow-up study. Nephrol Dial Transplant (2001) 0.94
Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol (1991) 0.93
Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval. Am J Kidney Dis (1998) 0.92
Recent advances in the clinical management of autosomal-dominant polycystic kidney disease. QJM (1996) 0.92
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int (1995) 0.91
Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol (1998) 0.90
Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int (1998) 0.90
Cyclosporin-diltiazem interaction. Lancet (1986) 0.90
Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus. Clin Nephrol (2008) 0.89
Norfloxacin and cyclosporine--a safe combination. Transplantation (1989) 0.89
Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment. Br Med J (1977) 0.87
Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol (1991) 0.87
Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int (2000) 0.87
Malakoplakia of the caecum in a kidney-transplant recipient: presentation as acute tumoral perforation and fatal outcome. Transpl Int (1999) 0.84
Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol (1994) 0.84
Mutation detection in the repeated part of the PKD1 gene. Am J Hum Genet (1997) 0.84
Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation (1982) 0.84
Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant (1997) 0.83
Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Transplant Proc (1987) 0.83
D-penicillamine induced crescentic glomerulonephritis: report and review of the literature. J Rheumatol (1987) 0.83
Cyclosporine-methyltestosterone interaction. Nephron (1991) 0.82
Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant (1997) 0.82
Outcome of HCV infection after renal transplantation. Kidney Int (1994) 0.82
Recurrent corneal erosion associated with Alport's syndrome. Rapid communication. Kidney Int (1997) 0.82
Epiphyseal impaction as a cause of severe osteoarticular pain of lower limbs after renal transplantation. Kidney Int (1993) 0.81
Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data. Aliment Pharmacol Ther (2013) 0.81
Confirmation of the crucial role of the recipient's maximal hydration on early diuresis of the human cadaver renal allograft. Transplantation (1983) 0.81
Early postoperative monitoring of natural anti-A and anti-B isoantibodies in ABO-incompatible living donor renal allografts. Transplant Proc (1987) 0.81
Diagnosis of epidemic and sporadic interstitial nephritis due to Hantaan-like virus in Belgium. Lancet (1984) 0.81
Prevalence, etiology, and treatment of late post-transplant hypertension. Adv Nephrol Necker Hosp (1983) 0.81
Indications for dialysis and transplantation in end-stage renal disease. Contrib Nephrol (1989) 0.81
Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int (1997) 0.81
Medullary sponge kidney--part of a congenital syndrome. Nephrol Dial Transplant (2001) 0.81
Importance of endogenous acid production in the regulation of acid-base equilibrium: the role of the digestive tract. Adv Nephrol Necker Hosp (1980) 0.81
[Anesthesia management in organ procurement: a fundamental stage in transplantation]. Agressologie (1986) 0.80
[Non-traumatic rupture of the Achilles tendon after renal transplantation]. Presse Med (1985) 0.80
Late-onset renal failure in Senior-Loken syndrome. Am J Kidney Dis (2000) 0.80